Ask AI
Beyond A1C in T2D TM 1

CE / CME

Looking Beyond A1C in T2D Care: Cardiovascular and Kidney Risk Assessment

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

ABIM MOC: maximum of 0.50 Medical Knowledge MOC point

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: August 10, 2026

Expiration: August 09, 2027

Activity

Progress
1 2 3
Course Completed

Introduction

In this module, Martin J. Abrahamson, MD, FACP, FRCP, discusses strategies healthcare professionals (HCPs) can take in moving type 2 diabetes (T2D) care beyond  A1C alone—with a focus on addressing cardiovascular–kidney–metabolic (CKM) health through comprehensive assessment, risk stratification, and treatment alignment following national and international guideline recommendations.

The key points discussed in this module are illustrated with thumbnails that can be enlarged by clicking on any of the slide thumbnails in the module alongside the expert commentary.

Before continuing with this educational activity, please take a moment to answer the following questions.

How many people with diabetes do you provide care for in a typical week?​

For those who practice in academic or community settings, please indicate your practice setting:

A 58-year-old person with T2D has a stable A1C at 7.3% on metformin. They also have hypertension, obesity, eGFR 58 mL/min/1.73 m², urine–albumin-to-creatinine ratio (UACR) 85 mg/g, blood pressure (BP) 142/84 mm Hg, and low-density lipoprotein cholesterol (LDL-C) 104 mg/dL. They have no known atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF) symptoms and express interest in weight loss but are concerned about adding another medication.

Which next step best reflects guideline-based primary care management beyond glycemic control?